SERA צמיחת הכנסות מרבעון לרבעון Sera Prognostics Inc.

Sera Prognostics leads the development of proteomic assays for the diagnosis of preterm labor, protecting its niche with patents. Quarterly revenue growth dynamics on GURU.Markets contain up-to-date data, where the value 162.70 reflects the metric balance. Growth is driven by the implementation of predictive tests, while the accuracy of results is guaranteed by the rapid thermal delivery of biomaterials via express services.
פילוחי מדדים מקיפים ואנליטיקה עבור seraprognostics.com (SERA)

Sera Prognostics operates in the defensive reproductive diagnostics sector, where demand remains stable regardless of market conditions. Quarterly revenue percentage growth reflects the pace of test integration into medical protocols and their recognition by insurers. This metric is calculated as the relative change in sales volume between the current and previous quarters, capturing the actual speed of business scaling. Positive momentum confirms the company's expansion, minimizing the risk of capital stagnation.